Phase I/II Study of Abraxane in Recurrent and Refractory Lymphoma

NCT01555853 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
20
Enrollment
OTHER
Sponsor class

Stopped completed accrual to phase I but drug did not show activity, so halted before initiation of phase II

Conditions

Interventions

Sponsor

Washington University School of Medicine